Cervomed Inc (CRVO)

09:27 AM

Is CervoMed Inc. a good long term investmentDouble or triple returns - Autocar Professional

09:27 AM

08:18 AM

CervoMed Inc. Stock Analysis and ForecastFree Technical Analysis Support - Autocar Professional

08:18 AM

07:15 AM

What analysts say about CervoMed Inc. stockFree Popular Stock Recommendations - Autocar Professional

07:15 AM

Jul 19, 2025

What drives CervoMed Inc. stock priceConsistently high returns - jammulinksnews.com

Jul 19, 2025

Jul 16, 2025

CervoMed’s Dementia Drug Saga Tests Investor Patience And Nerves - Finimize

Jul 16, 2025

Jul 15, 2025

How CervoMed Inc. stock performs during market volatilityStrategic High Profit Opportunities - Newser

Jul 15, 2025

Jul 15, 2025

Why CervoMed Inc. stock attracts strong analyst attentionTrend Based Entry Alerts - Newser

Jul 15, 2025

Jul 15, 2025

What makes CervoMed Inc. stock price move sharplyFree Stock Selection with 300% Return - Newser

Jul 15, 2025

Jul 13, 2025

Brokerages Set CervoMed Inc. (NASDAQ:CRVO) Price Target at $22.57 - Defense World

Jul 13, 2025

Jul 09, 2025

CervoMed Strengthens Leadership with Technical Operations Hire to Advance Neflamapimod Toward Phase 3 - MSN

Jul 09, 2025

Jul 08, 2025

CervoMed Inc. to Present Late-Breaking Data on Neflamapimod at Alzheimer’s Association International Congress 2025 - Nasdaq

Jul 08, 2025

Jul 08, 2025

CervoMed Announces Late-Breaking Presentations at Alzheimer’s Association® International Congress 2025 - GlobeNewswire

Jul 08, 2025

Jul 08, 2025

Late-Breaking Phase 2b Results: CervoMed's Novel DLB Drug Shows Effects on Clinical Progression - Stock Titan

Jul 08, 2025

Jun 30, 2025

CervoMed Inc.(NasdaqCM: CRVO) dropped from Russell 2000 Dynamic Index - MarketScreener

Jun 30, 2025

Jun 30, 2025

CervoMed Inc.(NasdaqCM: CRVO) dropped from Russell 3000E Index - MarketScreener

Jun 30, 2025

Jun 30, 2025

CervoMed Inc.(NasdaqCM: CRVO) dropped from Russell 2000 Index - MarketScreener

Jun 30, 2025

Jun 27, 2025

CervoMed Inc. (NASDAQ:CRVO) Shares Bought by Rhumbline Advisers - Defense World

Jun 27, 2025

Jun 25, 2025

CervoMed Stockholders Approve Key Proposals at Annual Meeting - TipRanks

Jun 25, 2025

Jun 15, 2025

CervoMed Inc. (NASDAQ:CRVO) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World

Jun 15, 2025

Jun 12, 2025

CervoMed’s (CRVO) “Buy” Rating Reaffirmed at D. Boral Capital - Defense World

Jun 12, 2025

Jun 11, 2025

CervoMed (CRVO) Receives Continued 'Buy' Rating with Target Pric - GuruFocus

Jun 11, 2025

Jun 11, 2025

CervoMed (CRVO) Receives Continued 'Buy' Rating with Target Price Held Steady | CRVO Stock News - GuruFocus

Jun 11, 2025

Jun 10, 2025

CervoMed (CRVO) Strengthens Leadership with Key Executive Appoin - GuruFocus

Jun 10, 2025

Jun 10, 2025

CervoMed (CRVO) Strengthens Leadership with Key Executive Appointment | CRVO Stock News - GuruFocus

Jun 10, 2025

Jun 10, 2025

CervoMed appoints Marco Verwijs as EVP, technical operations - TipRanks

Jun 10, 2025

Jun 10, 2025

CervoMed Announces New Hire to Support Neflamapimod Development and Commercialization - GlobeNewswire

Jun 10, 2025

Jun 10, 2025

CervoMed Accelerates Phase 3 DLB Drug Development With Key Manufacturing Expert Hire - Stock Titan

Jun 10, 2025

Jun 08, 2025

CRVOCervoMed Reports First Quarter 2025 Financial Results and Provides Corporate Updates - mx.advfn.com

Jun 08, 2025

Jun 07, 2025

Nuveen Asset Management LLC Acquires 22,104 Shares of CervoMed Inc. (NASDAQ:CRVO) - Defense World

Jun 07, 2025

Jun 05, 2025

BNP Paribas Financial Markets Purchases New Position in CervoMed Inc. (NASDAQ:CRVO) - Defense World

Jun 05, 2025

Jun 01, 2025

Reviewing CervoMed (CRVO) and Its Peers - Defense World

Jun 01, 2025

May 21, 2025

CervoMed Inc. (NASDAQ:CRVO) Given Average Rating of “Moderate Buy” by Analysts - Defense World

May 21, 2025

May 19, 2025

CervoMed Releases New Business and Financial Information - TipRanks

May 19, 2025

May 19, 2025

Pre-market Movers: CMRX, CPIX, PBM, CRVO... - RTTNews

May 19, 2025